company background image
600332 logo

Guangzhou Baiyunshan Pharmaceutical Holdings SHSE:600332 Stock Report

Last Price

CN¥29.06

Market Cap

CN¥44.5b

7D

0.1%

1Y

2.0%

Updated

22 Dec, 2024

Data

Company Financials +

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

SHSE:600332 Stock Report

Market Cap: CN¥44.5b

600332 Stock Overview

Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. More details

600332 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Guangzhou Baiyunshan Pharmaceutical Holdings
Historical stock prices
Current Share PriceHK$29.06
52 Week HighHK$33.72
52 Week LowHK$24.30
Beta0.58
1 Month Change3.56%
3 Month Change16.66%
1 Year Change1.96%
3 Year Change-11.16%
5 Year Change-13.85%
Change since IPO97.69%

Recent News & Updates

Recent updates

Shareholder Returns

600332CN HealthcareCN Market
7D0.1%-2.2%-1.2%
1Y2.0%-7.7%11.8%

Return vs Industry: 600332 exceeded the CN Healthcare industry which returned -7.7% over the past year.

Return vs Market: 600332 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 600332's price volatile compared to industry and market?
600332 volatility
600332 Average Weekly Movement4.6%
Healthcare Industry Average Movement8.3%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 600332 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600332's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199728,760Hong Liwww.gybys.com.cn

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical equipment, and healthcare products; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health maintenance, elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Fundamentals Summary

How do Guangzhou Baiyunshan Pharmaceutical Holdings's earnings and revenue compare to its market cap?
600332 fundamental statistics
Market capCN¥44.54b
Earnings (TTM)CN¥3.42b
Revenue (TTM)CN¥76.39b

8.0x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600332 income statement (TTM)
RevenueCN¥76.39b
Cost of RevenueCN¥63.46b
Gross ProfitCN¥12.93b
Other ExpensesCN¥9.50b
EarningsCN¥3.42b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.11
Gross Margin16.92%
Net Profit Margin4.48%
Debt/Equity Ratio35.5%

How did 600332 perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

55%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:01
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is covered by 29 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhi Xue DiaoAvic Securities Co., Ltd
null nullBOCI Research Ltd.
Feng Qiang SunBOCOM International Securities Limited